Stay updated on SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The record history shows the recruitment status changed from Active, not recruiting to Completed with a No longer looking for participants note; new status entries were added on 2026-06-04 and 2026-06-08, and the revision updated to v3.6.0.
    Difference
    0.6%
    Check dated 2026-06-12T16:40:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.5.4 to v3.5.5, indicating a software update to the page. This change does not alter study data or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-06-05T12:44:25.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Footer release tag updated to Revision: v3.5.4, reflecting a new platform version for the history page. The underlying study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-05-15T05:36:07.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page’s footer/application version was updated from **v3.5.2** to **v3.5.3** for the ClinicalTrials.gov interface.
    Difference
    0.0%
    Check dated 2026-04-23T22:09:04.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version 97 (2026-04-13) adds the Contacts/Locations and Study Status sections to the record history and updates the system to Revision: v3.5.2; the prior Revision: v3.5.0 was removed on 2026-03-18.
    Difference
    0.2%
    Check dated 2026-04-16T18:48:20.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Version 96 (2026-03-17) updates Study Status and Contacts/Locations; Revision: v3.5.0 is added on 2026-03-18.
    Difference
    0.2%
    Check dated 2026-03-18T20:29:37.000Z thumbnail image

Stay in the know with updates to SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page.